Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sucunamostat by Scohia Pharma for Phenylketonuria (PKU): Likelihood of Approval
Sucunamostat is under clinical development by Scohia Pharma and currently in Phase I for Phenylketonuria (PKU). According to GlobalData, Phase...
Sucunamostat by Scohia Pharma for Homocystinuria: Likelihood of Approval
Sucunamostat is under clinical development by Scohia Pharma and currently in Phase I for Homocystinuria. According to GlobalData, Phase I...
Sucunamostat by Scohia Pharma for Maple Syrup Urine Disease: Likelihood of Approval
Sucunamostat is under clinical development by Scohia Pharma and currently in Phase I for Maple Syrup Urine Disease. According to...
Sucunamostat by Scohia Pharma for Nephrotic Syndrome: Likelihood of Approval
Sucunamostat is under clinical development by Scohia Pharma and currently in Phase I for Nephrotic Syndrome. According to GlobalData, Phase...